JPS5927900A
(ja)
|
1982-08-09 |
1984-02-14 |
Wakunaga Seiyaku Kk |
固定化オリゴヌクレオチド
|
FR2540122B1
(fr)
|
1983-01-27 |
1985-11-29 |
Centre Nat Rech Scient |
Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
|
US4605735A
(en)
|
1983-02-14 |
1986-08-12 |
Wakunaga Seiyaku Kabushiki Kaisha |
Oligonucleotide derivatives
|
US4948882A
(en)
|
1983-02-22 |
1990-08-14 |
Syngene, Inc. |
Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis
|
US4824941A
(en)
|
1983-03-10 |
1989-04-25 |
Julian Gordon |
Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems
|
US4587044A
(en)
|
1983-09-01 |
1986-05-06 |
The Johns Hopkins University |
Linkage of proteins to nucleic acids
|
US5118802A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
DNA-reporter conjugates linked via the 2' or 5'-primary amino group of the 5'-terminal nucleoside
|
US5118800A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
Oligonucleotides possessing a primary amino group in the terminal nucleotide
|
FR2567892B1
(fr)
|
1984-07-19 |
1989-02-17 |
Centre Nat Rech Scient |
Nouveaux oligonucleotides, leur procede de preparation et leurs applications comme mediateurs dans le developpement des effets des interferons
|
US5258506A
(en)
|
1984-10-16 |
1993-11-02 |
Chiron Corporation |
Photolabile reagents for incorporation into oligonucleotide chains
|
US5430136A
(en)
|
1984-10-16 |
1995-07-04 |
Chiron Corporation |
Oligonucleotides having selectably cleavable and/or abasic sites
|
US4828979A
(en)
|
1984-11-08 |
1989-05-09 |
Life Technologies, Inc. |
Nucleotide analogs for nucleic acid labeling and detection
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
US4762779A
(en)
|
1985-06-13 |
1988-08-09 |
Amgen Inc. |
Compositions and methods for functionalizing nucleic acids
|
US5317098A
(en)
|
1986-03-17 |
1994-05-31 |
Hiroaki Shizuya |
Non-radioisotope tagging of fragments
|
JPS638396A
(ja)
|
1986-06-30 |
1988-01-14 |
Wakunaga Pharmaceut Co Ltd |
ポリ標識化オリゴヌクレオチド誘導体
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
US5585481A
(en)
|
1987-09-21 |
1996-12-17 |
Gen-Probe Incorporated |
Linking reagents for nucleotide probes
|
US5525465A
(en)
|
1987-10-28 |
1996-06-11 |
Howard Florey Institute Of Experimental Physiology And Medicine |
Oligonucleotide-polyamide conjugates and methods of production and applications of the same
|
DE3738460A1
(de)
|
1987-11-12 |
1989-05-24 |
Max Planck Gesellschaft |
Modifizierte oligonukleotide
|
US5082830A
(en)
|
1988-02-26 |
1992-01-21 |
Enzo Biochem, Inc. |
End labeled nucleotide probe
|
US5109124A
(en)
|
1988-06-01 |
1992-04-28 |
Biogen, Inc. |
Nucleic acid probe linked to a label having a terminal cysteine
|
US5262536A
(en)
|
1988-09-15 |
1993-11-16 |
E. I. Du Pont De Nemours And Company |
Reagents for the preparation of 5'-tagged oligonucleotides
|
US5759802A
(en)
|
1988-10-26 |
1998-06-02 |
Tonen Corporation |
Production of human serum alubumin A
|
US5512439A
(en)
|
1988-11-21 |
1996-04-30 |
Dynal As |
Oligonucleotide-linked magnetic particles and uses thereof
|
US5457183A
(en)
|
1989-03-06 |
1995-10-10 |
Board Of Regents, The University Of Texas System |
Hydroxylated texaphyrins
|
US5599923A
(en)
|
1989-03-06 |
1997-02-04 |
Board Of Regents, University Of Tx |
Texaphyrin metal complexes having improved functionalization
|
US5391723A
(en)
|
1989-05-31 |
1995-02-21 |
Neorx Corporation |
Oligonucleotide conjugates
|
US4958013A
(en)
|
1989-06-06 |
1990-09-18 |
Northwestern University |
Cholesteryl modified oligonucleotides
|
US5451463A
(en)
|
1989-08-28 |
1995-09-19 |
Clontech Laboratories, Inc. |
Non-nucleoside 1,3-diol reagents for labeling synthetic oligonucleotides
|
US5254469A
(en)
|
1989-09-12 |
1993-10-19 |
Eastman Kodak Company |
Oligonucleotide-enzyme conjugate that can be used as a probe in hybridization assays and polymerase chain reaction procedures
|
US5591722A
(en)
|
1989-09-15 |
1997-01-07 |
Southern Research Institute |
2'-deoxy-4'-thioribonucleosides and their antiviral activity
|
KR0185192B1
(ko)
|
1989-10-05 |
1999-04-01 |
제임스 더블유. 데이비 |
신규의 유전자 및 폴리펩티드의 무세포 합성 및 분리
|
ATE269870T1
(de)
|
1989-10-24 |
2004-07-15 |
Isis Pharmaceuticals Inc |
2'-modifizierte oligonukleotide
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
US5292873A
(en)
|
1989-11-29 |
1994-03-08 |
The Research Foundation Of State University Of New York |
Nucleic acids labeled with naphthoquinone probe
|
US5486603A
(en)
|
1990-01-08 |
1996-01-23 |
Gilead Sciences, Inc. |
Oligonucleotide having enhanced binding affinity
|
US5670633A
(en)
|
1990-01-11 |
1997-09-23 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides that detect and modulate gene expression
|
US7037646B1
(en)
|
1990-01-11 |
2006-05-02 |
Isis Pharmaceuticals, Inc. |
Amine-derivatized nucleosides and oligonucleosides
|
US5646265A
(en)
|
1990-01-11 |
1997-07-08 |
Isis Pharmceuticals, Inc. |
Process for the preparation of 2'-O-alkyl purine phosphoramidites
|
US6783931B1
(en)
|
1990-01-11 |
2004-08-31 |
Isis Pharmaceuticals, Inc. |
Amine-derivatized nucleosides and oligonucleosides
|
US5578718A
(en)
|
1990-01-11 |
1996-11-26 |
Isis Pharmaceuticals, Inc. |
Thiol-derivatized nucleosides
|
WO1991013080A1
(en)
|
1990-02-20 |
1991-09-05 |
Gilead Sciences, Inc. |
Pseudonucleosides and pseudonucleotides and their polymers
|
US5214136A
(en)
|
1990-02-20 |
1993-05-25 |
Gilead Sciences, Inc. |
Anthraquinone-derivatives oligonucleotides
|
CA2028849A1
(en)
|
1990-03-08 |
1991-09-09 |
Michinao Mizugaki |
Monoclonal antibodies, assay method, reagent kit, sarching method and drug missiles using them
|
GB9009980D0
(en)
|
1990-05-03 |
1990-06-27 |
Amersham Int Plc |
Phosphoramidite derivatives,their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
|
EP0455905B1
(en)
|
1990-05-11 |
1998-06-17 |
Microprobe Corporation |
Dipsticks for nucleic acid hybridization assays and methods for covalently immobilizing oligonucleotides
|
US5637459A
(en)
|
1990-06-11 |
1997-06-10 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chimeric selex
|
US5688941A
(en)
|
1990-07-27 |
1997-11-18 |
Isis Pharmaceuticals, Inc. |
Methods of making conjugated 4' desmethyl nucleoside analog compounds
|
US5218105A
(en)
|
1990-07-27 |
1993-06-08 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
US5489677A
(en)
|
1990-07-27 |
1996-02-06 |
Isis Pharmaceuticals, Inc. |
Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
|
US5602240A
(en)
|
1990-07-27 |
1997-02-11 |
Ciba Geigy Ag. |
Backbone modified oligonucleotide analogs
|
US5608046A
(en)
|
1990-07-27 |
1997-03-04 |
Isis Pharmaceuticals, Inc. |
Conjugated 4'-desmethyl nucleoside analog compounds
|
US5138045A
(en)
|
1990-07-27 |
1992-08-11 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
US5245022A
(en)
|
1990-08-03 |
1993-09-14 |
Sterling Drug, Inc. |
Exonuclease resistant terminally substituted oligonucleotides
|
US5512667A
(en)
|
1990-08-28 |
1996-04-30 |
Reed; Michael W. |
Trifunctional intermediates for preparing 3'-tailed oligonucleotides
|
CA2095212A1
(en)
|
1990-11-08 |
1992-05-09 |
Sudhir Agrawal |
Incorporation of multiple reporter groups on synthetic oligonucleotides
|
US5426180A
(en)
|
1991-03-27 |
1995-06-20 |
Research Corporation Technologies, Inc. |
Methods of making single-stranded circular oligonucleotides
|
US5714331A
(en)
|
1991-05-24 |
1998-02-03 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
|
US5539082A
(en)
|
1993-04-26 |
1996-07-23 |
Nielsen; Peter E. |
Peptide nucleic acids
|
US5719262A
(en)
|
1993-11-22 |
1998-02-17 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having amino acid side chains
|
US5371241A
(en)
|
1991-07-19 |
1994-12-06 |
Pharmacia P-L Biochemicals Inc. |
Fluorescein labelled phosphoramidites
|
US5437976A
(en)
|
1991-08-08 |
1995-08-01 |
Arizona Board Of Regents, The University Of Arizona |
Multi-domain DNA ligands bound to a solid matrix for protein and nucleic acid affinity chromatography and processing of solid-phase DNA
|
ES2103918T3
(es)
|
1991-10-17 |
1997-10-01 |
Ciba Geigy Ag |
Nucleosidos biciclicos, oligonucleotidos, procedimiento para su obtencion y productos intermedios.
|
US5359044A
(en)
|
1991-12-13 |
1994-10-25 |
Isis Pharmaceuticals |
Cyclobutyl oligonucleotide surrogates
|
KR940703846A
(ko)
|
1991-12-24 |
1994-12-12 |
비. 린네 파샬 |
갭(gap)이 형성된 2′ 변성된 올리고뉴클레오티드(gapped 2′ modifed oligonucleotides)
|
US5595726A
(en)
|
1992-01-21 |
1997-01-21 |
Pharmacyclics, Inc. |
Chromophore probe for detection of nucleic acid
|
US5565552A
(en)
|
1992-01-21 |
1996-10-15 |
Pharmacyclics, Inc. |
Method of expanded porphyrin-oligonucleotide conjugate synthesis
|
FR2687679B1
(fr)
|
1992-02-05 |
1994-10-28 |
Centre Nat Rech Scient |
Oligothionucleotides.
|
DE69231123T2
(de)
|
1992-03-25 |
2001-02-15 |
Immunogen Inc |
Konjugaten von Zell-bindender Mittel und Derivaten von CC-1065
|
EP0577558A2
(de)
|
1992-07-01 |
1994-01-05 |
Ciba-Geigy Ag |
Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte
|
US5272250A
(en)
|
1992-07-10 |
1993-12-21 |
Spielvogel Bernard F |
Boronated phosphoramidate compounds
|
ATE198253T1
(de)
|
1992-09-17 |
2001-01-15 |
Dsm Nv |
Hefederivate und verfahren zum verbessern der brotqualität
|
US5574142A
(en)
|
1992-12-15 |
1996-11-12 |
Microprobe Corporation |
Peptide linkers for improved oligonucleotide delivery
|
JPH08508492A
(ja)
|
1993-03-30 |
1996-09-10 |
スターリング ウィンスロップ インコーポレイティド |
非環式ヌクレオシド類似体及びそれらを含むオリゴヌクレオチド配列
|
DE4311944A1
(de)
|
1993-04-10 |
1994-10-13 |
Degussa |
Umhüllte Natriumpercarbonatpartikel, Verfahren zu deren Herstellung und sie enthaltende Wasch-, Reinigungs- und Bleichmittelzusammensetzungen
|
US6294664B1
(en)
|
1993-07-29 |
2001-09-25 |
Isis Pharmaceuticals, Inc. |
Synthesis of oligonucleotides
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
US5627053A
(en)
|
1994-03-29 |
1997-05-06 |
Ribozyme Pharmaceuticals, Inc. |
2'deoxy-2'-alkylnucleotide containing nucleic acid
|
US5597696A
(en)
|
1994-07-18 |
1997-01-28 |
Becton Dickinson And Company |
Covalent cyanine dye oligonucleotide conjugates
|
US5580731A
(en)
|
1994-08-25 |
1996-12-03 |
Chiron Corporation |
N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith
|
US5597909A
(en)
|
1994-08-25 |
1997-01-28 |
Chiron Corporation |
Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
FR2733762B1
(fr)
|
1995-05-02 |
1997-08-01 |
Genset Sa |
Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
|
US5808039A
(en)
|
1995-10-18 |
1998-09-15 |
Beckman Instruments, Inc. |
2'-OMe CAC phosphoramidite and methods for preparation and use thereof
|
US5871697A
(en)
|
1995-10-24 |
1999-02-16 |
Curagen Corporation |
Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
|
US6022737A
(en)
|
1995-11-02 |
2000-02-08 |
Amgen Inc. |
Formulations for non-viral in vivo transfection in the lungs
|
US5789578A
(en)
|
1996-01-11 |
1998-08-04 |
Massey University |
Methods for the preparation of resins with ligands attached thereto through a linking group comprising sulfide, sulfoxide or sulfone functionality
|
US7291463B2
(en)
|
1996-01-23 |
2007-11-06 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
EP0925088A2
(en)
|
1996-06-28 |
1999-06-30 |
Sontra Medical, L.P. |
Ultrasound enhancement of transdermal transport
|
US6475388B1
(en)
|
1996-11-13 |
2002-11-05 |
Transgenomic, Inc. |
Method and system for RNA analysis by matched ion polynucleotide chromatography
|
US6576752B1
(en)
|
1997-02-14 |
2003-06-10 |
Isis Pharmaceuticals, Inc. |
Aminooxy functionalized oligomers
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
GB2324370B
(en)
|
1997-04-14 |
1999-03-03 |
Stuart Harbron |
Detection of hybrid double-stranded DNA with antibody after enzyme degradation of excess single-standed DNA
|
US5989911A
(en)
|
1997-05-09 |
1999-11-23 |
University Of Massachusetts |
Site-specific synthesis of pseudouridine in RNA
|
US20030073640A1
(en)
|
1997-07-23 |
2003-04-17 |
Ribozyme Pharmaceuticals, Inc. |
Novel compositions for the delivery of negatively charged molecules
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
AU1275899A
(en)
|
1997-10-24 |
1999-05-17 |
Megabios Corporation |
Methods for preparing polynucleotide transfection complexes
|
US6548633B1
(en)
|
1998-12-22 |
2003-04-15 |
Genset, S.A. |
Complementary DNA's encoding proteins with signal peptides
|
US6267987B1
(en)
|
1997-12-12 |
2001-07-31 |
Samyang Corporation |
Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake
|
US6517869B1
(en)
|
1997-12-12 |
2003-02-11 |
Expression Genetics, Inc. |
Positively charged poly(alpha-(omega-aminoalkyl)lycolic acid) for the delivery of a bioactive agent via tissue and cellular uptake
|
US6320017B1
(en)
|
1997-12-23 |
2001-11-20 |
Inex Pharmaceuticals Corp. |
Polyamide oligomers
|
US8287483B2
(en)
|
1998-01-08 |
2012-10-16 |
Echo Therapeutics, Inc. |
Method and apparatus for enhancement of transdermal transport
|
AU740999B2
(en)
|
1998-01-08 |
2001-11-22 |
Sontra Medical, Inc. |
Sonophoretic enhanced transdermal transport
|
US5955310A
(en)
|
1998-02-26 |
1999-09-21 |
Novo Nordisk Biotech, Inc. |
Methods for producing a polypeptide in a bacillus cell
|
US6177274B1
(en)
|
1998-05-20 |
2001-01-23 |
Expression Genetics, Inc. |
Hepatocyte targeting polyethylene glyco-grafted poly-L-lysine polymeric gene carrier
|
MXPA01000271A
(es)
|
1998-07-13 |
2002-10-17 |
Expression Genetics Inc |
Analogo de poliester de poli-lisina como un portador para el suministro de genes, soluble, biodegradable.
|
US6248268B1
(en)
|
1998-11-16 |
2001-06-19 |
Xc Corporation |
Process of making microparticles of a thermally-gelled polysaccharide
|
US20040171980A1
(en)
|
1998-12-18 |
2004-09-02 |
Sontra Medical, Inc. |
Method and apparatus for enhancement of transdermal transport
|
CA2361201A1
(en)
|
1999-01-28 |
2000-08-03 |
Medical College Of Georgia Research Institute, Inc. |
Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
|
US8410248B2
(en)
|
1999-03-12 |
2013-04-02 |
Human Genome Sciences Inc. |
HWBAO62 polypeptides
|
US7084125B2
(en)
|
1999-03-18 |
2006-08-01 |
Exiqon A/S |
Xylo-LNA analogues
|
NZ514348A
(en)
|
1999-05-04 |
2004-05-28 |
Exiqon As |
L-ribo-LNA analogues
|
US6270970B1
(en)
|
1999-05-14 |
2001-08-07 |
Promega Corporation |
Mixed-bed solid phase and its use in the isolation of nucleic acids
|
CA2311201A1
(en)
|
1999-08-05 |
2001-02-05 |
Genset S.A. |
Ests and encoded human proteins
|
EP1818409A1
(en)
|
1999-09-09 |
2007-08-15 |
CureVac GmbH |
Transfer of mRNAusing polycationic compounds
|
IL148304A0
(en)
|
1999-09-10 |
2002-09-12 |
Geron Corp |
Oligonucleotide n3'-p5' thiophosphoramidates, their synthesis and use
|
US6511832B1
(en)
|
1999-10-06 |
2003-01-28 |
Texas A&M University System |
In vitro synthesis of capped and polyadenylated mRNAs using baculovirus RNA polymerase
|
US6818739B2
(en)
|
1999-12-03 |
2004-11-16 |
Ndsu Research Foundation |
Somatostatins
|
CA2392751A1
(en)
|
2000-01-31 |
2001-08-02 |
Craig A. Rosen |
Nucleic acids, proteins, and antibodies
|
WO2001055306A2
(en)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
US7491805B2
(en)
|
2001-05-18 |
2009-02-17 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
US7833992B2
(en)
|
2001-05-18 |
2010-11-16 |
Merck Sharpe & Dohme |
Conjugates and compositions for cellular delivery
|
US20020081597A1
(en)
|
2000-03-31 |
2002-06-27 |
Genentech, Inc. |
Compositions and methods for detecting and quantifying gene expression
|
WO2002000677A1
(en)
|
2000-06-07 |
2002-01-03 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
CA2421122A1
(en)
|
2000-09-01 |
2002-03-07 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
US6696038B1
(en)
|
2000-09-14 |
2004-02-24 |
Expression Genetics, Inc. |
Cationic lipopolymer as biocompatible gene delivery agent
|
US20040142474A1
(en)
|
2000-09-14 |
2004-07-22 |
Expression Genetics, Inc. |
Novel cationic lipopolymer as a biocompatible gene delivery agent
|
US6521411B2
(en)
|
2000-09-28 |
2003-02-18 |
Transgenomic, Inc. |
Method and system for the preparation of cDNA
|
DK1334109T3
(da)
|
2000-10-04 |
2006-10-09 |
Santaris Pharma As |
Forbedret syntese af purin-blokerede nukleinsyre-analoger
|
US7229765B2
(en)
|
2000-11-28 |
2007-06-12 |
Rosetta Inpharmatics Llc |
Random-primed reverse transcriptase-in vitro transcription method for RNA amplification
|
US20020130430A1
(en)
|
2000-12-29 |
2002-09-19 |
Castor Trevor Percival |
Methods for making polymer microspheres/nanospheres and encapsulating therapeutic proteins and other products
|
US20040142433A1
(en)
|
2001-02-02 |
2004-07-22 |
Padgett Hal S. |
Polynucleotide sequence variants
|
US6652886B2
(en)
|
2001-02-16 |
2003-11-25 |
Expression Genetics |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
|
US7211654B2
(en)
|
2001-03-14 |
2007-05-01 |
Regents Of The University Of Michigan |
Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports
|
US20050235369A1
(en)
|
2001-03-28 |
2005-10-20 |
Yen Choo |
Gene regulation II
|
DE50211110D1
(de)
|
2001-04-21 |
2007-12-06 |
Curevac Gmbh |
INJEKTIONSGERÄT FÜR mRNA APPLIKATION
|
AU2002254773B2
(en)
|
2001-05-03 |
2005-12-08 |
Rensselaer Polytechnic Institute |
Novel methods of directed evolution
|
US20030170891A1
(en)
|
2001-06-06 |
2003-09-11 |
Mcswiggen James A. |
RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US7514099B2
(en)
|
2005-02-14 |
2009-04-07 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
ES2240745T3
(es)
|
2001-06-05 |
2005-10-16 |
Curevac Gmbh |
Composicion farmaceutica que contiene un arnm estabilizado y optimizado para la traduccion, adecuada como vacuna y como regenerante de tejidos.
|
US7235358B2
(en)
*
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
US6586524B2
(en)
|
2001-07-19 |
2003-07-01 |
Expression Genetics, Inc. |
Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
AU2002347035B2
(en)
|
2001-09-28 |
2008-04-03 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V |
Micro-RNA molecules
|
EP1444347B1
(en)
|
2001-11-05 |
2005-11-23 |
Janssen Pharmaceutica N.V. |
METHOD FOR THE IN VITRO SYNTHESIS OF SHORT DOUBLE STRANDED RNAs
|
AU2002351077A1
(en)
|
2001-11-05 |
2003-05-19 |
Exiqon A/S |
Oligonucleotides modified with novel alpha-l-rna analogues
|
US20040076978A1
(en)
|
2001-11-14 |
2004-04-22 |
Catherine Verfaillie |
Method to identify genes associated with chronic myelogenous leukemia
|
AU2002359732A1
(en)
|
2001-12-17 |
2003-06-30 |
Ribapharm Inc. |
Substituted purine nucleoside libraries and compounds by solid-phase combinatorial strategies
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
AU2002366713A1
(en)
|
2001-12-20 |
2003-07-09 |
Incyte Genomics, Inc. |
Nucleotide polymorphisms associated with osteoarthritis
|
US20050222064A1
(en)
|
2002-02-20 |
2005-10-06 |
Sirna Therapeutics, Inc. |
Polycationic compositions for cellular delivery of polynucleotides
|
EP1487999B1
(en)
|
2002-03-15 |
2006-12-27 |
Epigenomics AG |
Discovery and diagnostic methods using 5-methylcytosine dna glycosylase
|
US7374930B2
(en)
|
2002-05-21 |
2008-05-20 |
Expression Genetics, Inc. |
GLP-1 gene delivery for the treatment of type 2 diabetes
|
AU2003288474A1
(en)
|
2002-06-24 |
2004-03-19 |
Exiqon A/S |
Methods and systems for detection and isolation of a nucleotide sequence
|
AU2003264041A1
(en)
|
2002-08-09 |
2004-02-25 |
California Institute Of Technology |
Method and compositions relating to 5'-chimeric ribonucleic acids
|
US7700758B2
(en)
|
2002-08-12 |
2010-04-20 |
New England Biolabs, Inc. |
Methods and compositions relating to gene silencing
|
KR100521309B1
(ko)
|
2002-08-31 |
2005-10-14 |
씨제이 주식회사 |
당쇄화된 인간 과립구 형성인자
|
US20060121441A1
(en)
|
2002-09-24 |
2006-06-08 |
Micha Spira |
Methods of determining the effect of an agent on diploid cells and/or on the pattern of expression of polypeptides expressed therewith
|
AU2003271050A1
(en)
|
2002-10-23 |
2004-06-07 |
Hubit Genomix, Inc. |
Genetic morphisms relating to periodontal diseases
|
EP1576126A3
(en)
|
2002-10-30 |
2005-10-26 |
Pointilliste, Inc. |
Systems for capture and analysis of biological particles and methods using the systems
|
KR101123489B1
(ko)
|
2003-01-16 |
2012-03-28 |
이데라 파마슈티칼즈, 인코포레이티드 |
개질된 면역자극성 디뉴클레오티드를 이용한 올리고뉴클레오티드-기재 화합물의 면역자극 특성의 조절
|
WO2004082703A1
(ja)
|
2003-03-20 |
2004-09-30 |
Keiichi Fukuda |
G-csfと血管新生作用を有する因子の併用
|
US8158354B2
(en)
|
2003-05-13 |
2012-04-17 |
Ibis Biosciences, Inc. |
Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
CA2528830A1
(en)
|
2003-06-10 |
2004-12-16 |
Toolgen, Inc. |
Transducible dna-binding proteins
|
WO2005013901A2
(en)
|
2003-07-31 |
2005-02-17 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
|
EP1660685A4
(en)
|
2003-09-12 |
2008-07-02 |
Cedars Sinai Medical Center |
ANTISENSE INHIBITION OF LAMINININ-8 EXPRESSION FOR THE INHIBITION OF HUMAN GLIOMES
|
CA2536139A1
(en)
|
2003-09-25 |
2005-04-07 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid-lipophilic conjugates
|
CA2547780C
(en)
|
2003-12-03 |
2019-10-22 |
Coda Therapeutics (Nz) Ltd |
Antisense compounds targeted to connexins and methods of use thereof
|
JP2008504803A
(ja)
|
2004-01-09 |
2008-02-21 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
遺伝子発現の細胞型特異的パターン
|
US8957034B2
(en)
|
2004-01-28 |
2015-02-17 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
US20080103053A1
(en)
|
2005-11-22 |
2008-05-01 |
Helicos Biosciences Corporation |
Methods and compositions for sequencing a nucleic acid
|
US7527947B2
(en)
|
2004-06-14 |
2009-05-05 |
Novozymes A/S |
Signal peptide for producing a polypeptide
|
DE102004035227A1
(de)
|
2004-07-21 |
2006-02-16 |
Curevac Gmbh |
mRNA-Gemisch zur Vakzinierung gegen Tumorerkrankungen
|
WO2006020768A2
(en)
|
2004-08-10 |
2006-02-23 |
Alnylam Pharmaceuticals, Inc. |
Chemically modified oligonucleotides
|
JP2008509168A
(ja)
|
2004-08-13 |
2008-03-27 |
マーシャル,バリー,ジェー. |
細菌デリバリシステム
|
JP4903146B2
(ja)
|
2004-08-16 |
2012-03-28 |
イミューン ディズィーズ インスティテュート インコーポレイテッド |
Rna干渉を送達する方法およびその使用法
|
US7361903B2
(en)
|
2004-09-01 |
2008-04-22 |
Koninklijke Philips Electronics N.V. |
Image system with non-circular patient aperture
|
EP2338993B1
(en)
|
2004-09-02 |
2013-06-12 |
Yale University |
Regulation of oncogenes by microRNAs
|
US8057821B2
(en)
|
2004-11-03 |
2011-11-15 |
Egen, Inc. |
Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
|
EP1817413B1
(en)
|
2004-11-11 |
2012-01-04 |
Modular Genetics, Inc. |
Oligonucleotide ladder assembly and system for generating molecular diversity
|
US7964571B2
(en)
|
2004-12-09 |
2011-06-21 |
Egen, Inc. |
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
|
US8354476B2
(en)
|
2004-12-10 |
2013-01-15 |
Kala Pharmaceuticals, Inc. |
Functionalized poly(ether-anhydride) block copolymers
|
FR2880345A1
(fr)
|
2004-12-30 |
2006-07-07 |
Adisseo Ireland Ltd |
Synthese et applications de l'acide 2-oxo-4-methylthiobutyrique, ses tels et ses derives
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
CN101495504A
(zh)
|
2005-06-30 |
2009-07-29 |
阿切埃米克斯有限公司 |
用于生产全2’-修饰的核酸转录产物的材料和方法
|
US8101385B2
(en)
|
2005-06-30 |
2012-01-24 |
Archemix Corp. |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
US20070141593A1
(en)
|
2005-08-22 |
2007-06-21 |
Lee Linda G |
Apparatus, system, and method using immiscible-fluid-discrete-volumes
|
EP4174179A3
(en)
|
2005-08-23 |
2023-09-27 |
The Trustees of the University of Pennsylvania |
Rna containing modified nucleosides and methods of use thereof
|
US9012219B2
(en)
|
2005-08-23 |
2015-04-21 |
The Trustees Of The University Of Pennsylvania |
RNA preparations comprising purified modified RNA for reprogramming cells
|
DE102005046490A1
(de)
|
2005-09-28 |
2007-03-29 |
Johannes-Gutenberg-Universität Mainz |
Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
|
US9157066B2
(en)
|
2005-12-13 |
2015-10-13 |
The Trustees Of The University Of Pennsylvania |
Transcriptome transfer produces cellular phenotype conversion
|
US20070161031A1
(en)
|
2005-12-16 |
2007-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Functional arrays for high throughput characterization of gene expression regulatory elements
|
WO2007089607A2
(en)
|
2006-01-26 |
2007-08-09 |
University Of Massachusetts |
Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same
|
EP1984381B1
(en)
|
2006-01-27 |
2010-09-29 |
Isis Pharmaceuticals, Inc. |
6-modified bicyclic nucleic acid analogs
|
EP2010659B1
(en)
|
2006-04-14 |
2014-06-18 |
CellScript, Inc. |
Kits and methods for generating 5' capped RNA
|
EP2397123A1
(en)
|
2006-07-07 |
2011-12-21 |
Aarhus Universitet |
Nanoparticles for nucleic acid delivery
|
US8304529B2
(en)
|
2006-07-28 |
2012-11-06 |
Life Technologies Corporation |
Dinucleotide MRNA cap analogs
|
US20100178272A1
(en)
|
2006-08-08 |
2010-07-15 |
Klinische Pharmakologie |
Structure and use of 5'phosphate oligonucleotides
|
ATE498393T1
(de)
|
2006-09-08 |
2011-03-15 |
Univ Johns Hopkins |
Zusammensetzungen zur transportintensivierung durch die schleimhaut
|
GB2445441B
(en)
|
2006-09-26 |
2010-06-30 |
Ge Healthcare Bio Sciences |
Nucleic acid purification method
|
CA2668818C
(en)
|
2006-10-10 |
2018-06-26 |
Xenomics, Inc. |
Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
DE102006061015A1
(de)
|
2006-12-22 |
2008-06-26 |
Curevac Gmbh |
Verfahren zur Reinigung von RNA im präparativen Maßstab mittels HPLC
|
CA2673029C
(en)
|
2006-12-22 |
2017-03-28 |
Archemix Corp. |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
WO2008103276A2
(en)
|
2007-02-16 |
2008-08-28 |
Merck & Co., Inc. |
Compositions and methods for potentiated activity of biologicaly active molecules
|
US20080220983A1
(en)
|
2007-03-08 |
2008-09-11 |
Switchgear Genomics A California Corporation |
Functional arrays for high throughput characterization of regulatory elements in untranslated regions of genes
|
GB0706243D0
(en)
|
2007-03-30 |
2007-05-09 |
Univ Southampton |
Modified nucleic acids
|
RU2435616C2
(ru)
|
2007-04-27 |
2011-12-10 |
Эко Терапьютикс, Инк. |
Устройство для повышения проницаемости кожи для обнаружения аналита или трансдермальтной доставки лекарственных препаратов
|
US7682789B2
(en)
|
2007-05-04 |
2010-03-23 |
Ventana Medical Systems, Inc. |
Method for quantifying biomolecules conjugated to a nanoparticle
|
US20080311140A1
(en)
|
2007-05-29 |
2008-12-18 |
Baylor College Of Medicine |
Antigen specific immunosuppression by dendritic cell therapy
|
US20090042825A1
(en)
|
2007-08-06 |
2009-02-12 |
Majed Matar |
Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
US8835621B2
(en)
|
2007-09-26 |
2014-09-16 |
Intrexon Corporation |
Synthetic 5'UTRs, expression vectors, and methods for increasing transgene expression
|
SI2644594T1
(sl)
|
2007-09-28 |
2017-10-30 |
Pfizer Inc. |
Ciljanje rakavih celic z uporabo nanodelcev
|
WO2009058911A2
(en)
|
2007-10-31 |
2009-05-07 |
Applied Biosystems Inc. |
Preparation and isolation of 5' capped mrna
|
US7871985B2
(en)
|
2007-12-10 |
2011-01-18 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of factor VII gene
|
WO2009074968A2
(en)
|
2007-12-12 |
2009-06-18 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Method for predicting the efficacy of cancer therapy
|
WO2009117167A1
(en)
|
2008-01-02 |
2009-09-24 |
Blood Cell Storage, Inc. |
Devices and processes for nucleic acid extraction
|
EP2548960B1
(en)
|
2008-01-31 |
2018-01-31 |
CureVac AG |
Nucleic acids comprising formula (nugixmgnv)a and derivatives thereof as an immunostimulating agents/adjuvant
|
WO2009108891A2
(en)
|
2008-02-29 |
2009-09-03 |
Egen, Inc. |
Modified poloxamers for gene expression and associated methods
|
CN102027043A
(zh)
|
2008-03-14 |
2011-04-20 |
艾根股份有限公司 |
生物可降解的交联支链聚(亚烷基亚胺)
|
WO2009142822A2
(en)
|
2008-03-26 |
2009-11-26 |
Alnylam Pharmaceuticals, Inc. |
2-f modified rna interference agents
|
DK2279254T3
(en)
|
2008-04-15 |
2017-09-18 |
Protiva Biotherapeutics Inc |
PRESENT UNKNOWN LIPID FORMS FOR NUCLEIC ACID ADMINISTRATION
|
WO2009127230A1
(en)
|
2008-04-16 |
2009-10-22 |
Curevac Gmbh |
MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
|
PL215513B1
(pl)
|
2008-06-06 |
2013-12-31 |
Univ Warszawski |
Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
|
EP2294196A1
(en)
|
2008-06-06 |
2011-03-16 |
Centre National de la Recherche Scientifique - CNRS |
Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna
|
JP2012501966A
(ja)
|
2008-06-16 |
2012-01-26 |
バインド バイオサイエンシズ インコーポレイテッド |
ビンカアルカロイド含有治療用ポリマーナノ粒子並びにその製造方法及び使用方法
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
SI2285350T1
(en)
|
2008-06-16 |
2018-03-30 |
Pfizer Inc. |
Methods for the preparation of diblock copolymers functionalized with targeting agent for use in the manufacture of therapeutic nanoparticles
|
JP6363320B2
(ja)
|
2008-06-16 |
2018-07-25 |
ファイザー・インク |
薬剤を装填したポリマーナノ粒子及びその製造方法と使用方法
|
US20100009424A1
(en)
|
2008-07-14 |
2010-01-14 |
Natasha Forde |
Sonoporation systems and methods
|
CA2731760C
(en)
|
2008-07-24 |
2019-09-24 |
Meiji Seika Kaisha, Ltd. |
Pyripyropene a biosynthetic gene
|
EP2304026A4
(en)
*
|
2008-07-31 |
2013-12-18 |
Belrose Pharma Inc |
NANOPARTICLE COMPOSITIONS FOR A NUCLEIC ACID DELIVERY SYSTEM
|
WO2010013815A1
(ja)
|
2008-08-01 |
2010-02-04 |
協和発酵キリン株式会社 |
標的遺伝子の発現を抑制する組成物
|
WO2010017510A1
(en)
|
2008-08-07 |
2010-02-11 |
University Of Southern California |
A system for synergistic expression of multiple small functional rna elements
|
WO2010021865A1
(en)
|
2008-08-18 |
2010-02-25 |
Merck Sharp & Dohme Corp. |
Novel lipid nanoparticles and novel components for delivery of nucleic acids
|
US20100087337A1
(en)
|
2008-09-10 |
2010-04-08 |
Bind Biosciences, Inc. |
High Throughput Fabrication of Nanoparticles
|
US20100075072A1
(en)
|
2008-09-25 |
2010-03-25 |
Tsung-Wei Chen |
Decorative structure of tree-shaped bells
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
US8969353B2
(en)
|
2008-11-07 |
2015-03-03 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
EP2379064B1
(en)
|
2008-12-15 |
2020-02-26 |
Pfizer Inc. |
Long circulating nanoparticles for sustained release of therapeutic agents
|
US8367330B2
(en)
|
2008-12-22 |
2013-02-05 |
Quest Diagnostics Investments Incorporated |
Methods for detecting TCR-gamma gene rearrangement
|
WO2010080724A1
(en)
|
2009-01-12 |
2010-07-15 |
Merck Sharp & Dohme Corp. |
Novel lipid nanoparticles and novel components for delivery of nucleic acids
|
US8669085B2
(en)
|
2009-02-05 |
2014-03-11 |
Ut-Battelle, Llc |
Transformation of gram positive bacteria by sonoporation
|
ES2931174T3
(es)
|
2009-03-20 |
2022-12-27 |
Egen Inc |
Derivados de poliamina
|
AU2010227247B2
(en)
|
2009-03-24 |
2015-10-22 |
Council Of Scientific & Industrial Research |
Process for the preparation of agarose polymer from seaweed extractive
|
US20100261228A1
(en)
|
2009-04-09 |
2010-10-14 |
California Institute Of Technology |
Multiplexed sites for polymer synthesis
|
AU2010239689A1
(en)
|
2009-04-21 |
2011-11-03 |
Selecta Biosciences, Inc. |
Immunonanotherapeutics providing a Th1-biased response
|
US20100273220A1
(en)
*
|
2009-04-22 |
2010-10-28 |
Massachusetts Institute Of Technology |
Innate immune suppression enables repeated delivery of long rna molecules
|
EP3028707A1
(en)
|
2009-05-01 |
2016-06-08 |
Ophthotech Corporation |
Methods for treating or preventing ophthalmological diseases
|
KR20210031549A
(ko)
|
2009-05-05 |
2021-03-19 |
알닐람 파마슈티칼스 인코포레이티드 |
지질 조성물
|
CA2762650A1
(en)
|
2009-05-27 |
2010-12-02 |
Selecta Biosciences, Inc. |
Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
|
SI3431076T1
(sl)
*
|
2009-06-10 |
2022-04-29 |
Arbutus Biopharma Corporation |
Izboljšana lipidna formulacija
|
US8765370B2
(en)
|
2009-06-11 |
2014-07-01 |
Scinopharm Taiwan, Ltd |
Inhibition-based high-throughput screen strategy for cell clones
|
US9512164B2
(en)
|
2009-07-07 |
2016-12-06 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotide end caps
|
WO2011005850A1
(en)
|
2009-07-07 |
2011-01-13 |
The Research Foundation Of State University Of New York |
Lipidic compositions for induction of immune tolerance
|
WO2011008260A2
(en)
|
2009-07-13 |
2011-01-20 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
EP2459231B1
(de)
|
2009-07-31 |
2016-06-08 |
Ethris Gmbh |
Rna mit einer kombination aus unmodifizierten und modifizierten nucleotiden zur proteinexpression
|
US8598327B2
(en)
|
2009-08-18 |
2013-12-03 |
Baxter International Inc. |
Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics
|
EP2467357B1
(en)
|
2009-08-20 |
2016-03-30 |
Sirna Therapeutics, Inc. |
Novel cationic lipids with various head groups for oligonucleotide delivery
|
GB2473814B
(en)
|
2009-09-16 |
2014-06-11 |
Spheritech Ltd |
Hollow particulate support
|
EP2485770A4
(en)
|
2009-10-08 |
2013-04-10 |
Merck Sharp & Dohme |
NEW CATIONIC LIPIDS WITH SHORT LIPID CHAINS FOR ADMINISTRATION OF OLIGONUCLEOTIDES
|
CN107028886A
(zh)
*
|
2009-11-04 |
2017-08-11 |
不列颠哥伦比亚大学 |
含有核酸的脂质粒子及相关的方法
|
TR201901311T4
(tr)
|
2009-12-01 |
2019-02-21 |
Translate Bio Inc |
İnsan genetik hastalıklarında mRNA'nın teslimi için steroid türevi.
|
LT3287525T
(lt)
|
2009-12-07 |
2020-02-10 |
The Trustees Of The University Of Pennsylvania |
Rnr preparatai, apimantys išgrynintą modifikuotą rnr, skirti ląstelių reprogramavimui
|
CN102811743B
(zh)
|
2009-12-11 |
2015-11-25 |
佰恩德治疗股份有限公司 |
冻干治疗颗粒的稳定制剂
|
EA201290498A1
(ru)
|
2009-12-15 |
2013-01-30 |
Байнд Байосайенсиз, Инк. |
Терапевтические полимерные наночастицы, включающие эпотилон, и способы их получения и применения
|
JP6175237B2
(ja)
|
2009-12-15 |
2017-08-02 |
ファイザー・インク |
コルチコステロイドを含む治療用ポリマーナノ粒およびそれを製造かつ使用する方法
|
JP5965844B2
(ja)
|
2009-12-15 |
2016-08-10 |
バインド セラピューティックス インコーポレイテッド |
高いガラス転移温度または高分子量のコポリマーを有する治療用ポリマーナノ粒子組成物
|
EP2518144B1
(en)
|
2009-12-21 |
2015-08-05 |
Hiroshima University |
Aging marker, method for evaluating aging inhibitor, and cancer inhibitor
|
JP2011130725A
(ja)
|
2009-12-25 |
2011-07-07 |
Contig I:Kk |
Lnaオリゴヌクレオチドとそれを含有する化粧品
|
WO2011085231A2
(en)
|
2010-01-08 |
2011-07-14 |
Selecta Biosciences, Inc. |
Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines
|
EP2525781A1
(en)
|
2010-01-22 |
2012-11-28 |
Schering Corporation |
Novel cationic lipids for oligonucleotide delivery
|
JP6204664B2
(ja)
|
2010-02-26 |
2017-09-27 |
キアゲン ゲーエムベーハー |
Rnaおよびdnaの並行単離および/または並行精製のためのプロセス
|
US20110218170A1
(en)
|
2010-03-02 |
2011-09-08 |
Southern Research Institute |
Use of 2'-deoxy-4'-thiocytidine and its analogues as dna hypomethylating anticancer agents
|
WO2011115862A1
(en)
|
2010-03-18 |
2011-09-22 |
Merck Sharp & Dohme Corp. |
Endosomolytic poly(amidoamine) disulfide polymers for the delivery of oligonucleotides
|
US20130037977A1
(en)
|
2010-04-08 |
2013-02-14 |
Paul A. Burke |
Preparation of Lipid Nanoparticles
|
US20110262491A1
(en)
|
2010-04-12 |
2011-10-27 |
Selecta Biosciences, Inc. |
Emulsions and methods of making nanocarriers
|
EP2377938A1
(en)
|
2010-04-16 |
2011-10-19 |
Eukarys |
Capping-prone RNA polymerase enzymes and their applications
|
EP3540059A1
(en)
|
2010-04-16 |
2019-09-18 |
Nuevolution A/S |
Bi-functional complexes and methods for making and using such complexes
|
WO2011130624A2
(en)
|
2010-04-16 |
2011-10-20 |
Immune Disease Institute, Inc. |
Sustained polypeptide expression from synthetic, modified rnas and uses thereof
|
US20130260460A1
(en)
|
2010-04-22 |
2013-10-03 |
Isis Pharmaceuticals Inc |
Conformationally restricted dinucleotide monomers and oligonucleotides
|
WO2011149733A2
(en)
|
2010-05-24 |
2011-12-01 |
Merck Sharp & Dohme Corp. |
Novel amino alcohol cationic lipids for oligonucleotide delivery
|
CN102985437B
(zh)
|
2010-05-28 |
2016-05-25 |
弗·哈夫曼-拉罗切有限公司 |
通过下调ldh和pdhk表达降低乳酸水平和增加多肽生产
|
JP5957646B2
(ja)
|
2010-06-04 |
2016-07-27 |
サーナ・セラピューティクス・インコーポレイテッドSirna Therapeutics,Inc. |
オリゴヌクレオチド送達のための新規な低分子量カチオン性脂質
|
JP6061849B2
(ja)
|
2010-07-06 |
2017-01-18 |
ノバルティス アーゲー |
自己複製rna分子についてのビリオン様送達粒子
|
EP2600901B1
(en)
|
2010-08-06 |
2019-03-27 |
ModernaTX, Inc. |
A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
|
CA2809851A1
(en)
*
|
2010-08-31 |
2012-03-08 |
Novartis Ag |
Pegylated liposomes for delivery of immunogen-encoding rna
|
US9669097B2
(en)
|
2010-09-20 |
2017-06-06 |
Sirna Therapeutics, Inc. |
Low molecular weight cationic lipids for oligonucleotide delivery
|
JP2013545723A
(ja)
|
2010-09-30 |
2013-12-26 |
メルク・シャープ・エンド・ドーム・コーポレイション |
オリゴヌクレオチドの送達のための低分子量カチオン性脂質
|
US20120237975A1
(en)
|
2010-10-01 |
2012-09-20 |
Jason Schrum |
Engineered nucleic acids and methods of use thereof
|
US10078075B2
(en)
|
2011-12-09 |
2018-09-18 |
Vanderbilt University |
Integrated organ-on-chip systems and applications of the same
|
US8898864B1
(en)
|
2010-10-08 |
2014-12-02 |
David Porter |
Integrated rockably released leverage snap fastening system
|
EP2629802B1
(en)
|
2010-10-21 |
2019-12-04 |
Sirna Therapeutics, Inc. |
Low molecular weight cationic lipids for oligonucleotide delivery
|
JP2013543844A
(ja)
|
2010-10-22 |
2013-12-09 |
バインド セラピューティックス インコーポレイテッド |
高分子コポリマーを含む治療用ナノ粒子
|
WO2012061703A1
(en)
|
2010-11-05 |
2012-05-10 |
The Johns Hopkins University |
Compositions and methods relating to reduced mucoadhesion
|
EP2635265B1
(en)
|
2010-11-05 |
2018-04-04 |
Sirna Therapeutics, Inc. |
Novel low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery
|
EP2640400A4
(en)
|
2010-11-19 |
2016-01-20 |
Sirna Therapeutics Inc |
POLYMERIC POLYMERS (AMIDE) FOR THE ADMINISTRATION OF OLIGONUCLEOTIDES
|
WO2012082574A1
(en)
|
2010-12-17 |
2012-06-21 |
Merck Sharp & Dohme Corp. |
Membrane lytic poly(amido amine) polymers for the delivery of oligonucleotides
|
WO2012092552A1
(en)
|
2010-12-30 |
2012-07-05 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers with reactive groups that release biologically active agents
|
EP2661255B1
(en)
|
2011-01-04 |
2021-03-10 |
Brown University |
Nanotubes as carriers of nucleic acids into cells
|
EP3202760B1
(en)
|
2011-01-11 |
2019-08-21 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
DE102011082231A1
(de)
|
2011-01-12 |
2012-07-12 |
Robert Bosch Gmbh |
Zündspule, insbesondere für kleinbauende Motoren
|
US20120189700A1
(en)
|
2011-01-19 |
2012-07-26 |
Zoraida Aguilar |
Nanoparticle Based Immunological Stimulation
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
EP2694524B1
(en)
|
2011-04-04 |
2016-05-18 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
2'-o-aminooxymethyl nucleoside derivatives for use in the synthesis and modification of nucleosides, nucleotides and oligonucleotides
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
CA2835428A1
(en)
|
2011-05-17 |
2012-11-22 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof for non-human vertebrates
|
WO2012164565A1
(en)
|
2011-06-01 |
2012-12-06 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for downregulating prokaryotic genes
|
US20130046083A1
(en)
|
2011-08-16 |
2013-02-21 |
Tom Brown |
Oligonucleotide ligation
|
US8846883B2
(en)
|
2011-08-16 |
2014-09-30 |
University Of Southhampton |
Oligonucleotide ligation
|
WO2013036294A1
(en)
|
2011-09-06 |
2013-03-14 |
Selecta Biosciences, Inc. |
Antigen-specific induced tolerogenic dendritic cells to reduce cytotoxic t lymphocyte responses
|
US20130066063A1
(en)
|
2011-09-09 |
2013-03-14 |
John Cooke Hodges |
Bicyclo[6.1.0]non-4-yne regents for chemical modification of oligonucleotides
|
WO2013039857A1
(en)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
EP3384938A1
(en)
|
2011-09-12 |
2018-10-10 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
RS62993B1
(sr)
|
2011-10-03 |
2022-03-31 |
Modernatx Inc |
Modifikovani nukleozidi, nukleotidi, i nukleinske kiseline, i njihove upotrebe
|
PL2773326T3
(pl)
*
|
2011-11-04 |
2019-06-28 |
Nitto Denko Corporation |
Sposób sterylnego wytwarzania cząstek lipid-kwas nukleinowy
|
US9579338B2
(en)
*
|
2011-11-04 |
2017-02-28 |
Nitto Denko Corporation |
Method of producing lipid nanoparticles for drug delivery
|
WO2013071047A1
(en)
|
2011-11-11 |
2013-05-16 |
Children's Medical Center Corporation |
Compositions and methods for in vitro transcription of rna
|
US8450107B1
(en)
|
2011-11-30 |
2013-05-28 |
The Broad Institute Inc. |
Nucleotide-specific recognition sequences for designer TAL effectors
|
EP2788006A1
(en)
*
|
2011-12-07 |
2014-10-15 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
WO2013086486A1
(en)
|
2011-12-09 |
2013-06-13 |
President And Fellows Of Harvard College |
Integrated human organ-on-chip microphysiological systems
|
WO2013086502A1
(en)
|
2011-12-09 |
2013-06-13 |
President And Fellows Of Harvard College |
Organ chips and uses thereof
|
CA2858884A1
(en)
|
2011-12-12 |
2013-06-20 |
The Trustees Of The University Of Pennsylvania |
Proteins comprising mrsa pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat mrsa infections
|
US20140343129A1
(en)
|
2011-12-14 |
2014-11-20 |
Moderna Therapeutics, Inc. |
Modified nucleic acids, and acute care uses thereof
|
US20140378538A1
(en)
|
2011-12-14 |
2014-12-25 |
Moderma Therapeutics, Inc. |
Methods of responding to a biothreat
|
WO2013090897A1
(en)
|
2011-12-15 |
2013-06-20 |
The Trustees Of The University Of Pennsylvania |
Using adaptive immunity to detect drug resistance
|
WO2013090648A1
(en)
|
2011-12-16 |
2013-06-20 |
modeRNA Therapeutics |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
JP2015510495A
(ja)
|
2011-12-21 |
2015-04-09 |
モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. |
器官または器官移植片の生存可能性または寿命を延長する方法
|
EP2797634A4
(en)
|
2011-12-29 |
2015-08-05 |
Moderna Therapeutics Inc |
MODIFIED mRNA ENCODING POLYPEPTIDES PENETRATING IN CELLS
|
PL3144389T3
(pl)
|
2011-12-30 |
2018-10-31 |
Cellscript, Llc |
WYTWARZANIE I STOSOWANIE ZSYNTETYZOWANEGO IN VITRO ssRNA DO WPROWADZANIA DO SSACZYCH KOMÓREK W CELU INDUKCJI EFEKTU BIOLOGICZNEGO LUB BIOCHEMICZNEGO
|
WO2013103659A1
(en)
|
2012-01-04 |
2013-07-11 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
|
WO2013106496A1
(en)
|
2012-01-10 |
2013-07-18 |
modeRNA Therapeutics |
Methods and compositions for targeting agents into and across the blood-brain barrier
|
WO2013113325A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Negatively charged nucleic acid comprising complexes for immunostimulation
|
WO2013113326A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
|
CN103325662B
(zh)
|
2012-03-21 |
2016-03-30 |
清华大学 |
半导体性单壁碳纳米管的制备方法
|
US20150050354A1
(en)
|
2012-04-02 |
2015-02-19 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the treatment of otic diseases and conditions
|
CN108949772A
(zh)
|
2012-04-02 |
2018-12-07 |
现代泰克斯公司 |
用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
|
EP3501550A1
(en)
|
2012-04-02 |
2019-06-26 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
EP2647426A1
(en)
|
2012-04-03 |
2013-10-09 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Replication of distributed nucleic acid molecules with preservation of their relative distribution through hybridization-based binding
|
US20150150996A1
(en)
|
2012-06-06 |
2015-06-04 |
Northwestern University |
Compositions and methods for antigen-specific tolerance
|
EA201492055A1
(ru)
|
2012-06-08 |
2015-11-30 |
Шир Хьюман Дженетик Терапис, Инк. |
ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ
|
EP2885419A4
(en)
|
2012-08-14 |
2016-05-25 |
Moderna Therapeutics Inc |
ENZYMES AND POLYMERASES FOR RNA SYNTHESIS
|
US20150307542A1
(en)
|
2012-10-03 |
2015-10-29 |
Moderna Therapeutics, Inc. |
Modified nucleic acid molecules and uses thereof
|
SI2922554T1
(sl)
|
2012-11-26 |
2022-06-30 |
Modernatx, Inc. |
Terminalno modificirana RNA
|
BR112015013784A2
(pt)
*
|
2012-12-12 |
2017-07-11 |
Massachusetts Inst Technology |
aplicação, manipulação e otimização de sistemas, métodos e composições para manipulação de sequência e aplicações terapêuticas
|
ES2598115T3
(es)
*
|
2012-12-12 |
2017-01-25 |
The Broad Institute, Inc. |
Ingeniería de sistemas, métodos y composiciones de guía optimizadas para manipulación de secuencias
|
WO2014093574A1
(en)
|
2012-12-13 |
2014-06-19 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for altering cell phenotype
|
CA2897941A1
(en)
|
2013-01-17 |
2014-07-24 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
WO2014164253A1
(en)
|
2013-03-09 |
2014-10-09 |
Moderna Therapeutics, Inc. |
Heterologous untranslated regions for mrna
|
WO2014160284A1
(en)
|
2013-03-14 |
2014-10-02 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of stroke
|
EP2971010B1
(en)
|
2013-03-14 |
2020-06-10 |
ModernaTX, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
US20160032316A1
(en)
|
2013-03-14 |
2016-02-04 |
The Trustees Of The University Of Pennsylvania |
Purification and Purity Assessment of RNA Molecules Synthesized with Modified Nucleosides
|
EP3750903A1
(en)
|
2013-03-14 |
2020-12-16 |
Translate Bio, Inc. |
Ribonucleic acids with 4'-thio-modified nucleotides and related methods
|
US10077439B2
(en)
|
2013-03-15 |
2018-09-18 |
Modernatx, Inc. |
Removal of DNA fragments in mRNA production process
|
EP2983804A4
(en)
|
2013-03-15 |
2017-03-01 |
Moderna Therapeutics, Inc. |
Ion exchange purification of mrna
|
US20140273230A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Sigma-Aldrich Co., Llc |
Crispr-based genome modification and regulation
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
US20160032273A1
(en)
|
2013-03-15 |
2016-02-04 |
Moderna Therapeutics, Inc. |
Characterization of mrna molecules
|
EP2971033B8
(en)
|
2013-03-15 |
2019-07-10 |
ModernaTX, Inc. |
Manufacturing methods for production of rna transcripts
|
US20160017313A1
(en)
|
2013-03-15 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Analysis of mrna heterogeneity and stability
|
US11377470B2
(en)
|
2013-03-15 |
2022-07-05 |
Modernatx, Inc. |
Ribonucleic acid purification
|
EP2981617B1
(en)
|
2013-04-04 |
2023-07-05 |
President and Fellows of Harvard College |
Therapeutic uses of genome editing with crispr/cas systems
|
JP2016528890A
(ja)
|
2013-07-09 |
2016-09-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
CRISPR/Cas系を用いるゲノム編集の治療用の使用
|
SI3019619T1
(sl)
|
2013-07-11 |
2021-12-31 |
Modernatx, Inc. |
Sestave, ki zajemajo sintetične polinukleotide, ki kodirajo proteine, pozvezane s crispr, in sintetične sgrna, ter metode uporabe
|
BR112016003127A2
(pt)
|
2013-08-16 |
2017-10-17 |
Rana Therapeutics Inc |
composições e métodos para modular rna
|
WO2015034928A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
EP3043826A4
(en)
|
2013-09-13 |
2017-05-24 |
Moderna Therapeutics, Inc. |
Polynucleotide compositions containing amino acids
|
EP3052106A4
(en)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
GB201317301D0
(en)
|
2013-09-30 |
2013-11-13 |
Linnarsson Sten |
Method for capturing and encoding nucleic acid from a plurality of single cells
|
WO2015051173A2
(en)
|
2013-10-02 |
2015-04-09 |
Moderna Therapeutics, Inc |
Polynucleotide molecules and uses thereof
|
EP3052511A4
(en)
|
2013-10-02 |
2017-05-31 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
US10323076B2
(en)
|
2013-10-03 |
2019-06-18 |
Modernatx, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
WO2015058069A1
(en)
|
2013-10-18 |
2015-04-23 |
Moderna Therapeutics, Inc. |
Compositions and methods for tolerizing cellular systems
|
WO2015070413A1
(zh)
|
2013-11-14 |
2015-05-21 |
深圳智慧能源技术有限公司 |
陶瓷热屏蔽片及耐热结构
|
WO2015085318A2
(en)
|
2013-12-06 |
2015-06-11 |
Moderna Therapeutics, Inc. |
Targeted adaptive vaccines
|
US20150167017A1
(en)
|
2013-12-13 |
2015-06-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
ES2712092T3
(es)
|
2013-12-30 |
2019-05-09 |
Curevac Ag |
Moléculas de ácido nucleico artificiales
|
EP3092250A4
(en)
|
2014-01-08 |
2017-05-24 |
Moderna Therapeutics, Inc. |
Polynucleotides for the in vivo production of antibodies
|
EP3981437A1
(en)
|
2014-04-23 |
2022-04-13 |
ModernaTX, Inc. |
Nucleic acid vaccines
|
EP3157572A4
(en)
|
2014-06-19 |
2018-02-14 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
WO2015196128A2
(en)
|
2014-06-19 |
2015-12-23 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
US20170136132A1
(en)
|
2014-06-19 |
2017-05-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
WO2016011222A2
(en)
|
2014-07-16 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
EP3169309B1
(en)
|
2014-07-16 |
2023-05-10 |
Novartis AG |
Method of encapsulating a nucleic acid in a lipid nanoparticle host
|
JP2017524357A
(ja)
|
2014-07-16 |
2017-08-31 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
キメラポリヌクレオチド
|
WO2016036902A1
(en)
|
2014-09-03 |
2016-03-10 |
Moderna Therapeutics, Inc. |
Tolerogenic compositions and methods
|
EP3041948B1
(en)
|
2014-11-10 |
2019-01-09 |
Modernatx, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
US20180000953A1
(en)
|
2015-01-21 |
2018-01-04 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
US20180085474A1
(en)
|
2015-01-23 |
2018-03-29 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
DK3294885T3
(da)
|
2015-05-08 |
2020-08-10 |
Curevac Real Estate Gmbh |
Fremgangsmåde til at fremstille rna
|
WO2017070613A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Human cytomegalovirus vaccine
|